DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Vimta Labs Limited — Acquisition

NSE 1d ago·30 Oct 2026, 2:29 pm

Vimta Labs

Vimta Labs Limited has announced the incorporation of a wholly-owned subsidiary in the United States. This new entity will serve as the company's operational base for its international business activities.

This strategic move is significant for investors as it strengthens Vimta Labs' global footprint. By establishing a direct presence in the US, the company aims to enhance its service delivery and expand its market reach in the international arena.

Investors should monitor the subsidiary's progress and its contribution to Vimta Labs' overall revenue. The success of this expansion will be a key indicator of the company's ability to scale its operations beyond domestic markets.